Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,090 | -47,903 | -39,300 | -2,187 | 11,216 |
| Depreciation Amortization | 4,571 | 17,888 | 13,297 | 8,850 | 4,443 |
| Income taxes - deferred | -2,064 | -22,661 | -10,999 | -12,286 | -5,070 |
| Accounts receivable | 3,076 | -6,090 | -2,544 | -4,153 | -927 |
| Accounts payable and accrued liabilities | -4,626 | -2,916 | 3,278 | 650 | -3,560 |
| Other Working Capital | -3,216 | 5,211 | 2,964 | -4,874 | -5,802 |
| Other Operating Activity | 9,942 | 53,030 | 38,356 | 14,423 | -3,867 |
| Operating Cash Flow | $-3,407 | $-3,441 | $5,052 | $423 | $-3,567 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,440 | -24,591 | -59,407 | -8,643 | -7,157 |
| PPE Investments | -838 | -1,428 | -61 | -24 | -24 |
| Net Acquisitions | N/A | -615 | -500 | -500 | N/A |
| Purchase Sale Intangibles | -3,477 | -10,496 | -7,632 | -4,881 | -2,575 |
| Other Investing Activity | -3,477 | 37,004 | 39,868 | -4,881 | -2,575 |
| Investing Cash Flow | $4,125 | $10,370 | $-20,100 | $-14,048 | $-9,756 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,964 | 10,021 | 8,223 | 1,572 | 781 |
| Other Financing Activity | -1,818 | -13,870 | -7,028 | -4,415 | -1,707 |
| Financing Cash Flow | $146 | $-3,849 | $1,195 | $-2,843 | $-926 |
| Exchange Rate Effect | 4 | 117 | -57 | -182 | -294 |
| Beginning Cash Position | 41,002 | 37,805 | 37,805 | 37,805 | 37,805 |
| End Cash Position | 41,870 | 41,002 | 23,895 | 21,155 | 23,262 |
| Net Cash Flow | $868 | $3,197 | $-13,910 | $-16,650 | $-14,543 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,407 | -3,441 | 5,052 | 423 | -3,567 |
| Capital Expenditure | -838 | -1,428 | -61 | -24 | -24 |
| Free Cash Flow | -4,245 | -4,869 | 4,991 | 399 | -3,591 |